Dynatrace Receives Buy Rating Amidst Strong Subscription Growth and Strategic Advancements
William Blair analyst Jake Roberge has maintained their bullish stance on DT stock, giving a Buy rating today.Invest with Confidence: Follow ...
pharmaphorum51m
HCP marketing’s Pharma 4.0 moment: Leveraging AI for real-time campaign optimisation
The growing use of AI has opened new avenues for healthcare marketers, revolutionising how they approach new initiatives. With the Pharma 4.0 term representing the pharmaceutical industry's adaptation ...